Human Placental Mesenchymal Stem Cells (pMSCs) Play a Role as Immune Suppressive Cells by Shifting Macrophage Differentiation from Inflammatory M1 to Anti-inflammatory M2 Macrophages

Stem Cell Reviews and Reports

Volumn 9, Issue 5, 2013, Pages 620-641

  Abumaree, M H ^a,b   Al Jumah, M A ^a,b   Kalionis, B ^c,d   Jawdat, D ^a,b   Al Khaldi, A ^a,b   Abomaray, F M ^b   Fatani, A S ^a   Chamley, L W ^e   Knawy, B A ^a,b  

^a KING SAUD BIN ABDULAZIZ UNIVERSITY FOR HEALTH SCIENCES   (Saudi Arabia)

^b KING SAUD BIN ABDULAZIZ UNIVERSITY FOR HEALTH SCIENCES   (Saudi Arabia)

^c UNIVERSITY OF MELBOURNE   (Australia)

^d ROYAL WOMEN'S HOSPITAL   (Australia)

^e UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

Immune suppression; Inflammation; Macrophages; Placenta mesenchymal stem cells

Indexed keywords

CYTOCHALASIN B; CYTOKINE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HLA ANTIGEN CLASS 2; LEUKOCYTE ANTIGEN;

APOPTOSIS; ARTICLE; BONE MARROW CELL; CELL CULTURE; CELL DIFFERENTIATION; COCULTURE; CYTOLOGY; DRUG EFFECT; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HUMAN; IMMUNOLOGY; MACROPHAGE; MESENCHYMAL STROMA CELL; METABOLISM; MONOCYTE; PHAGOCYTOSIS; PLACENTA; PREGNANCY;

ANTIGENS, CD; APOPTOSIS; BONE MARROW CELLS; CELL DIFFERENTIATION; CELLS, CULTURED; COCULTURE TECHNIQUES; CYTOCHALASIN B; CYTOKINES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HISTOCOMPATIBILITY ANTIGENS CLASS II; HUMANS; MACROPHAGES; MESENCHYMAL STROMAL CELLS; MONOCYTES; PHAGOCYTOSIS; PLACENTA; PREGNANCY;

EID: 84884814863     PISSN: 15508943     EISSN: 15586804     Source Type: Journal    
DOI: 10.1007/s12015-013-9455-2     Document Type: Article

References (63)

1. Porada, C. D., Zanjani, E. D., & Almeida-Porad, G. (2006). Adult mesenchymal stem cells: a pluripotent population with multiple applications. Current Stem Cell Research & Therapy, 1, 365-369.
2. Abumaree, M. H., Al Jumah, M. A., Kalionis, B., et al. (2013). Phenotypic and functional characterization of mesenchymal stem cells from chorionic villi of human term placenta. Stem Cell Reviews, 9, 16-31.
3. Al Jumah, M. A., & Abumaree, M. H. (2012). The immunomodulatory and neuroprotective effects of mesenchymal stem cells (MSCs) in experimental autoimmune encephalomyelitis (EAE): a model of multiple sclerosis (MS). International Journal of Molecular Sciences, 13, 9298-9331.
4. Abumaree, M., Al Jumah, M., Pace, R. A., Kalionis, B. (2011). Immunosuppressive properties of mesenchymal stem cells. Stem Cell Reviews.
5. Kim, J., & Hematti, P. (2009). Mesenchymal stem cell-educated macrophages: a novel type of alternatively activated macrophages. Experimental Hematology, 37, 1445-1453.
6. Maggini, J., Mirkin, G., Bognanni, I., et al. (2010). Mouse bone marrow-derived mesenchymal stromal cells turn activated macrophages into a regulatory-like profile. PLoS One, 5, e9252.
7. Zhang, Q. Z., Su, W. R., Shi, S. H., et al. (2010). Human gingiva-derived mesenchymal stem cells elicit polarization of m2 macrophages and enhance cutaneous wound healing. Stem Cells, 28, 1856-1868.
8. Dayan, V., Yannarelli, G., Billia, F., et al. (2011). Mesenchymal stromal cells mediate a switch to alternatively activated monocytes/macrophages after acute myocardial infarction. Basic Research in Cardiology, 106, 1299-1310.
9. Nemeth, K., Leelahavanichkul, A., Yuen, P. S., et al. (2009). Bone marrow stromal cells attenuate sepsis via prostaglandin E(2)-dependent reprogramming of host macrophages to increase their interleukin-10 production. Nature Medicine, 15, 42-49.
10. Gupta, N., Su, X., Popov, B., Lee, J. W., Serikov, V., & Matthay, M. A. (2007). Intrapulmonary delivery of bone marrow-derived mesenchymal stem cells improves survival and attenuates endotoxin-induced acute lung injury in mice. Journal of Immunology, 179, 1855-1863.
11. Adutler-Lieber, S., Ben-Mordechai, T., Naftali-Shani, N., et al. (2013). Human macrophage regulation via interaction with cardiac adipose tissue-derived mesenchymal stromal cells. Journal of Cardiovascular Pharmacology and Therapeutics, 18, 78-86.
12. Murray, P. J., & Wynn, T. A. (2011). Protective and pathogenic functions of macrophage subsets. Nature Reviews Immunology, 11, 723-737.
13. Palucka, K. A., Taquet, N., Sanchez-Chapuis, F., & Gluckman, J. C. (1998). Dendritic cells as the terminal stage of monocyte differentiation. Journal of Immunology, 160, 4587-4595.
14. Svensson, J., Jenmalm, M., Matussek, A., Geffers, R., Berg, G., & Ernerudh, J. (2011). Macrophages at the fetal-maternal interface express markers of alternative activation and are induced by M-CSF and IL-10. Journal of Immunology, 7, 3671-3682.
15. Jeannin, P., Duluc, D., & Delneste, Y. (2011). IL-6 and leukemia-inhibitory factor are involved in the generation of tumor-associated macrophage: regulation by IFN-gamma. Immunotherapy, 3, 23-26.
16. Buechler, C., Ritter, M., Orso, E., Langmann, T., Klucken, J., & Schmitz, G. (2000). Regulation of scavenger receptor CD163 expression in human monocytes and macrophages by pro- and antiinflammatory stimuli. Journal of Leukocyte Biology, 67, 97-103.
17. Heusinkveld, M., de Vos van Steenwijk, P. J., Goedemans, R., et al. (2011). M2 macrophages induced by prostaglandin E2 and IL-6 from cervical carcinoma are switched to activated M1 macrophages by CD4+ Th1 cells. Journal of Immunology, 187, 1157-1165.
18. Rickard, A. J., & Young, M. J. (2009). Corticosteroid receptors, macrophages and cardiovascular disease. Journal of Molecular Endocrinology, 42, 449-459.
19. Prewitt, C. M., Niesman, I. R., Kane, C. J., & Houle, J. D. (1997). Activated macrophage/microglial cells can promote the regeneration of sensory axons into the injured spinal cord. Experimental Neurology, 148, 433-443.
20. Chernykh, E. R., Shevela, E. Y., Sakhno, L. V., Tikhonova, M. A., Petrovsky, Y. L., Ostanin, A. A. (2010). The generation and properties of human M2-like macrophages: potential candidates for CNS repair? Cellular Therapy and Transplantation, 2.
21. Kigerl, K. A., Gensel, J. C., Ankeny, D. P., Alexander, J. K., Donnelly, D. J., & Popovich, P. G. (2009). Identification of two distinct macrophage subsets with divergent effects causing either neurotoxicity or regeneration in the injured mouse spinal cord. The Journal of Neuroscience: The Official Journal of the Society for Neuroscience, 29, 13435-13444.
22. Svensson, J. J. M., Matussek, A., Geffers, R., Berg, G., & Ernerudh, J. (2011). Macrophages at the fetal-maternal interface express markers of alternative activation and are induced by M-CSF and IL-10. Journal of Immunology, 187(7), 3671-3682.
23. Tait, A. S., Butts, C. L., & Sternberg, E. M. (2008). The role of glucocorticoids and progestins in inflammatory, autoimmune, and infectious disease. Journal of Leukocyte Biology, 84, 924-931.
24. Abumaree, M. H., Chamley, L. W., Badri, M., & El-Muzaini, M. F. (2012). Trophoblast debris modulates the expression of immune proteins in macrophages: a key to maternal tolerance of the fetal allograft? Journal of Reproductive Immunology, 94, 131-141.
25. Waldo, S. W., Li, Y., Buono, C., et al. (2008). Heterogeneity of human macrophages in culture and in atherosclerotic plaques. The American Journal of Pathology, 172, 1112-1126.
26. Jiang, X. X., Zhang, Y., Liu, B., et al. (2005). Human mesenchymal stem cells inhibit differentiation and function of monocyte-derived dendritic cells. Blood, 105, 4120-4126.
27. Wang, M., Yang, Y., Yang, D., et al. (2009). The immunomodulatory activity of human umbilical cord blood-derived mesenchymal stem cells in vitro. Immunology, 126, 220-232.
28. Jung-Testas, I., & Baulieu, E. E. (1983). Inhibition of glucocorticosteroid action in cultured L-929 mouse fibroblasts by RU 486, a new anti-glucocorticosteroid of high affinity for the glucocorticosteroid receptor. Experimental Cell Research, 147, 177-182.
29. Heng, B. C., Ye, C. P., Liu, H., et al. (2006). Loss of viability during freeze-thaw of intact and adherent human embryonic stem cells with conventional slow-cooling protocols is predominantly due to apoptosis rather than cellular necrosis. Journal of Biomedical Science, 13, 433-445.
30. Verreck, F. A., de Boer, T., Langenberg, D. M., van der Zanden, L., & Ottenhoff, T. H. (2006). Phenotypic and functional profiling of human proinflammatory type-1 and anti-inflammatory type-2 macrophages in response to microbial antigens and IFN-gamma- and CD40L-mediated costimulation. Journal of Leukocyte Biology, 79, 285-293.
31. Lolmede, K., Campana, L., Vezzoli, M., et al. (2009). Inflammatory and alternatively activated human macrophages attract vessel-associated stem cells, relying on separate HMGB1- and MMP-9-dependent pathways. Journal of Leukocyte Biology, 85, 779-787.
32. Komohara, Y., Ohnishi, K., Kuratsu, J., & Takeya, M. (2008). Possible involvement of the M2 anti-inflammatory macrophage phenotype in growth of human gliomas. The Journal of Pathology, 216, 15-24.
33. Kryczek, I., Zou, L., Rodriguez, P., et al. (2006). B7-H4 expression identifies a novel suppressive macrophage population in human ovarian carcinoma. The Journal of Experimental Medicine, 203, 871-881.
34. Gordon, S. (2003). Alternative activation of macrophages. Nature Reviews Immunology, 3, 23-35.
35. Mosser, D. M., & Edwards, J. P. (2008). Exploring the full spectrum of macrophage activation. Nature Reviews Immunology, 8, 958-969.
36. Serhan, C. N. (2007). Resolution phase of inflammation: novel endogenous anti-inflammatory and proresolving lipid mediators and pathways. Annual Review of Immunology, 25, 101-137.
37. Ravichandran, K. S., & Lorenz, U. (2007). Engulfment of apoptotic cells: signals for a good meal. Nature Reviews Immunology, 7, 964-974.
38. Erwig, L. P., & Henson, P. M. (2008). Clearance of apoptotic cells by phagocytes. Cell Death and Differentiation, 15, 243-250.
39. Anton, K., Banerjee, D., & Glod, J. (2012). Macrophage-associated mesenchymal stem cells assume an activated, migratory, pro-inflammatory phenotype with increased IL-6 and CXCL10 secretion. PLoS One, 7, e35036.
40. Sallusto, F., & Lanzavecchia, A. (1994). Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha. The Journal of Experimental Medicine, 179, 1109-1118.
41. Li, Y., Li, X. C., Zheng, X. X., Wells, A. D., Turka, L. A., & Strom, T. B. (1999). Blocking both signal 1 and signal 2 of T-cell activation prevents apoptosis of alloreactive T cells and induction of peripheral allograft tolerance. Nature Medicine, 5, 1298-1302.
42. Ou, D., Wang, X., Metzger, D. L., et al. (2006). Suppression of human T-cell responses to beta-cells by activation of B7-H4 pathway. Cell Transplantation, 15, 399-410.
43. Prasad, D. V., Richards, S., Mai, X. M., & Dong, C. (2003). B7S1, a novel B7 family member that negatively regulates T cell activation. Immunity, 18, 863-873.
44. Wang, X., Hao, J., Metzger, D. L., et al. (2009). Local expression of B7-H4 by recombinant adenovirus transduction in mouse islets prolongs allograft survival. Transplantation, 87, 482-490.
45. Ozkaynak, E., Wang, L., Goodearl, A., et al. (2002). Programmed death-1 targeting can promote allograft survival. Journal of Immunology, 169, 6546-6553.
46. Watford, W. T., Moriguchi, M., Morinobu, A., & O'Shea, J. J. (2003). The biology of IL-12: coordinating innate and adaptive immune responses. Cytokine & Growth Factor Reviews, 14, 361-368.
47. Lichtman, A. H., Chin, J., Schmidt, J. A., & Abbas, A. K. (1988). Role of interleukin 1 in the activation of T lymphocytes. Proceedings of the National Academy of Sciences of the United States of America, 85, 9699-9703.
48. Di Nicola, M., Carlo-Stella, C., Magni, M., et al. (2002). Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. Blood, 99, 3838-3843.
49. Tse, W. T., Pendleton, J. D., Beyer, W. M., Egalka, M. C., & Guinan, E. C. (2003). Suppression of allogeneic T-cell proliferation by human marrow stromal cells: implications in transplantation. Transplantation, 75, 389-397.
50. Rasmusson, I., Ringden, O., Sundberg, B., & Le Blanc, K. (2003). Mesenchymal stem cells inhibit the formation of cytotoxic T lymphocytes, but not activated cytotoxic T lymphocytes or natural killer cells. Transplantation, 76, 1208-1213.
51. Groh, M. E., Maitra, B., Szekely, E., & Koc, O. N. (2005). Human mesenchymal stem cells require monocyte-mediated activation to suppress alloreactive T cells. Experimental Hematology, 33, 928-934.
52. Corcione, A., Benvenuto, F., Ferretti, E., et al. (2006). Human mesenchymal stem cells modulate B-cell functions. Blood, 107, 367-372.
53. Dwyer, R. M., Khan, S., Barry, F. P., O'Brien, T., & Kerin, M. J. (2010). Advances in mesenchymal stem cell-mediated gene therapy for cancer. Stem Cell Research & Therapy, 1, 25.
54. Platt, N., Suzuki, H., Kurihara, Y., Kodama, T., & Gordon, S. (1996). Role for the class A macrophage scavenger receptor in the phagocytosis of apoptotic thymocytes in vitro. Proceedings of the National Academy of Sciences of the United States of America, 93, 12456-12460.
55. Greenberg, M. E., Sun, M., Zhang, R., Febbraio, M., Silverstein, R., & Hazen, S. L. (2006). Oxidized phosphatidylserine-CD36 interactions play an essential role in macrophage-dependent phagocytosis of apoptotic cells. The Journal of Experimental Medicine, 203, 2613-2625.
56. Devitt, A., Pierce, S., Oldreive, C., Shingler, W. H., & Gregory, C. D. (2003). CD14-dependent clearance of apoptotic cells by human macrophages: the role of phosphatidylserine. Cell Death and Differentiation, 10, 371-382.
57. Schaer, D. J., Alayash, A. I., & Buehler, P. W. (2007). Gating the radical hemoglobin to macrophages: the anti-inflammatory role of CD163, a scavenger receptor. Antioxidants & Redox Signaling, 9, 991-999.
58. Philippidis, P., Mason, J. C., Evans, B. J., et al. (2004). Hemoglobin scavenger receptor CD163 mediates interleukin-10 release and heme oxygenase-1 synthesis: antiinflammatory monocyte-macrophage responses in vitro, in resolving skin blisters in vivo, and after cardiopulmonary bypass surgery. Circulation Research, 94, 119-126.
59. Hamann, W., Floter, A., Schmutzler, W., & Zwadlo-Klarwasser, G. (1995). Characterization of a novel anti-inflammatory factor produced by RM3/1 macrophages derived from glucocorticoid treated human monocytes. Inflammation Research, 44, 535-540.
60. Goerdt, S., & Orfanos, C. E. (1999). Other functions, other genes: alternative activation of antigen-presenting cells. Immunity, 10, 137-142.
61. Holland, O., Medvedeva, N., McDowell-Hook, M., Abumaree, M., & Chamley, L. (2012). Syncytial nuclear aggregates, carriers of fetal alloantigens. Journal of Reproductive Immunology, 94, 118.
62. Reyes-Moreno, C., Frenette, G., Boulanger, J., Lavergne, E., Govindan, M. V., & Koutsilieris, M. (1995). Mediation of glucocorticoid receptor function by transforming growth factor beta I expression in human PC-3 prostate cancer cells. The Prostate, 26, 260-269.
63. Miller, A. H., Pariante, C. M., & Pearce, B. D. (1999). Effects of cytokines on glucocorticoid receptor expression and function. Glucocorticoid resistance and relevance to depression. Advances in Experimental Medicine and Biology, 461, 107-116.